Search research articles
Contact Us
Filters
Showing results (1-10 of 145) with videos related to
Page
of 15
Sort By:
Current Medicinal Chemistry
|
March 7, 2006
AMP-activated protein kinase and type 2 diabetes
Nicolas Musi
The American Journal of Medicine
|
September 24, 2011
Improving treatment in Hispanic/Latino patients
Eugenio Cersosimo, Nicolas Musi
Expert Opinion on Drug Discovery
|
March 16, 2013
Advances in the development of AMPK-activating compounds
Apiradee Sriwijitkamol, Nicolas Musi
Endocrine
|
April 20, 2006
Insulin resistance and improvements in signal transduction
Nicolas Musi, Laurie J Goodyear
Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|
December 13, 2002
Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes
Nicolas Musi, Laurie J Goodyear
American Journal of Physiology. Cell Physiology
|
November 19, 2011
Potential role of insulin signaling on vascular smooth muscle cell migration, proliferation, and inflammation pathways
Eugenio Cersosimo, Xiaojing Xu, Nicolas Musi
Diabetes, Obesity & Metabolism
|
October 10, 2006
AMP-activated protein kinase: Role in metabolism and therapeutic implications
Greg Schimmack, Ralph A Defronzo, Nicolas Musi
Physiological Reports
|
August 21, 2014
Acute insulin resistance stimulates and insulin sensitization attenuates vascular smooth muscle cell migration and proliferation
Eugenio Cersosimo, Xiaojing Xu, Sikarin Upala, et al.
Endocrinology
|
June 7, 2018
SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet β Cells
Jia Nie, Chao Sun, Zhijie Chang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2007
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazone
Estela Wajcberg, Apiradee Sriwijitkamol, Nicolas Musi, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 145) with videos related to
Sort By:
Page
of 15
Current Medicinal Chemistry
|
March 7, 2006
AMP-activated protein kinase and type 2 diabetes
Nicolas Musi
The American Journal of Medicine
|
September 24, 2011
Improving treatment in Hispanic/Latino patients
Eugenio Cersosimo, Nicolas Musi
Expert Opinion on Drug Discovery
|
March 16, 2013
Advances in the development of AMPK-activating compounds
Apiradee Sriwijitkamol, Nicolas Musi
Endocrine
|
April 20, 2006
Insulin resistance and improvements in signal transduction
Nicolas Musi, Laurie J Goodyear
Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|
December 13, 2002
Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes
Nicolas Musi, Laurie J Goodyear
American Journal of Physiology. Cell Physiology
|
November 19, 2011
Potential role of insulin signaling on vascular smooth muscle cell migration, proliferation, and inflammation pathways
Eugenio Cersosimo, Xiaojing Xu, Nicolas Musi
Diabetes, Obesity & Metabolism
|
October 10, 2006
AMP-activated protein kinase: Role in metabolism and therapeutic implications
Greg Schimmack, Ralph A Defronzo, Nicolas Musi
Physiological Reports
|
August 21, 2014
Acute insulin resistance stimulates and insulin sensitization attenuates vascular smooth muscle cell migration and proliferation
Eugenio Cersosimo, Xiaojing Xu, Sikarin Upala, et al.
Endocrinology
|
June 7, 2018
SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet β Cells
Jia Nie, Chao Sun, Zhijie Chang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2007
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazone
Estela Wajcberg, Apiradee Sriwijitkamol, Nicolas Musi, et al.
Page
of 15